GoodRx Holdings (GDRX) Cash from Operations Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 53.64% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 21.01% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 50.65% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 774.78% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 11.20% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 32.16% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -23.96% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -105.58% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 110.23% |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | 25.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.76% |
| Dec 31, 2025 | -26.50% |
| Sep 30, 2025 | -12.48% |
| Jun 30, 2025 | 411.08% |
| Mar 31, 2025 | -77.90% |
| Dec 31, 2024 | 181.97% |
| Sep 30, 2024 | 44.12% |
| Jun 30, 2024 | -67.52% |
| Mar 31, 2024 | 31.89% |
| Dec 31, 2023 | -50.22% |
| Sep 30, 2023 | 78.67% |
| Jun 30, 2023 | -41.50% |
| Mar 31, 2023 | 7.20% |
| Dec 31, 2022 | -36.00% |
| Sep 30, 2022 | -30.53% |
| Jun 30, 2022 | 46.16% |
| Mar 31, 2022 | -33.78% |
| Dec 31, 2021 | 235.42% |
| Sep 30, 2021 | 48.65% |
| Jun 30, 2021 | -8.65% |
| Mar 31, 2021 | -0.23% |
| Dec 31, 2020 | -10.08% |